S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Sarepta Therapeutics Announces Favorable Safety Results from Phase I Clinical Study of Influenza Drug Candidate|
|Sarepta Therapeutics Announces Publication of Ebola and Marburg Phase I Clinical Study Results in Antimicrobial Agents and Chemotherapy|
|Sarepta Therapeutics Announces Regulatory Update on Eteplirsen|
|Sarepta Therapeutics Announces Third Quarter 2014 Financial Results and Recent Corporate Developments|
|Sarepta Therapeutics Announces First Patient Dosed in Study of Eteplirsen in Non-Ambulant Patients with Duchenne Muscular Dystrophy|
|Sarepta Therapeutics Announces First Patient Dosed in Confirmatory Study of Eteplirsen in Ambulant Patients with Duchenne Muscular Dystrophy|
|Sarepta Therapeutics to Host Webcast and Conference Call for the Duchenne Muscular Dystrophy Community on December 2, 2014|
|Sarepta Therapeutics Announces Presentations at the 19th International Congress of the World Muscle Society|
|Sarepta Therapeutics to Present at Leerink Partners Rare Disease Roundtable|
|Sarepta Therapeutics to Present Company Overview at Upcoming Conferences|
Click above to view more mutual fund data and stats for ab3a - Sarepta Therapeutics Inc.